Top Authors

• Most frequent coverage on CRGN

• 
  Ohad Hammer (173 followers)

  • Curagen: Positive Results at ASCO 2009 (Tue, Jul 7)
  • Top Biotech Picks for ASCO 2009 (Part II) (Wed, May 27)
  • Top Biotech Picks for ASCO 2009 (Part I) (Wed, May 27)

  More by Ohad Hammer on CRGN »
• 
  Zacks.com (1024 followers)

  • Four Biotech Stocks with 'Free' Pipelines (Thu, May 14)
  • CuraGen Caught in the Middle (Sat, Apr 11)

  More by Zacks.com on CRGN »
• 
  Mike Havrilla (1907 followers)

  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO (Mon, Jun 1)
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches (Mon, May 18)

  More by Mike Havrilla on CRGN »

• Most followed authors on CRGN

• 
  Mike Havrilla (1907 followers)

  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO (Mon, Jun 1)
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches (Mon, May 18)

  More by Mike Havrilla on CRGN »
• 
  Zacks.com (1024 followers)

  • Four Biotech Stocks with 'Free' Pipelines (Thu, May 14)
  • CuraGen Caught in the Middle (Sat, Apr 11)

  More by Zacks.com on CRGN »
• 
  The Manual of Ideas (363 followers)

  • 20 Graham and Dodd Net / Nets (Mon, Jan 26)

  More by The Manual of Ideas on CRGN »

• Newest authors on CRGN

• 
  The Burrill Report (173 followers)

  • Two Potential Mega Biotech Deals Fuel Industry Hopes (Sun, May 31)

  More by The Burrill Report on CRGN »
• 
  Greenbackd (87 followers)

  • CuraGen Presents an Opportune Time to Exit (Mon, May 18)
  • Performance and Update of Our Undervalued Assets Portfolio (Mon, Mar 2)

  More by Greenbackd on CRGN »
• 
  The Manual of Ideas (363 followers)

  • 20 Graham and Dodd Net / Nets (Mon, Jan 26)

  More by The Manual of Ideas on CRGN »

• Most commented on CRGN

• 
  Ohad Hammer (173 followers)

  • Curagen: Positive Results at ASCO 2009 (Tue, Jul 7)
  • Top Biotech Picks for ASCO 2009 (Part II) (Wed, May 27)
  • Top Biotech Picks for ASCO 2009 (Part I) (Wed, May 27)

  More by Ohad Hammer on CRGN »
• 
  Mike Havrilla (1907 followers)

  • FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO (Mon, Jun 1)
  • Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches (Mon, May 18)

  More by Mike Havrilla on CRGN »
• 
  Greenbackd (87 followers)

  • CuraGen Presents an Opportune Time to Exit (Mon, May 18)
  • Performance and Update of Our Undervalued Assets Portfolio (Mon, Mar 2)

  More by Greenbackd on CRGN »